Overview

Efficacy and Safety Study of the Effect of Dose-Titration of Prucalopride for The Treatment of Chronic Constipation

Status:
Completed
Trial end date:
1999-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety profile of 4 mg prucalopride in the treatment of chronic constipation.
Phase:
Phase 3
Details
Lead Sponsor:
Movetis
Treatments:
Prucalopride